Psilocybin and Alcohol Use Disorder Study

If you are between 18-70 years of age and have a desire to reduce or stop alcohol consumption, you may be eligible to participate in a study involving psilocybin-assisted psychotherapy.

The purpose of this study is to evaluate the effectiveness of psilocybin (“magic mushrooms”) versus a placebo when combined with therapy on potentially decreasing excessive alcohol use. In previous studies, psilocybin-assisted therapy demonstrated the potential to alter alcohol reliance and diminish heavy drinking days.

All study-related care will be provided at no cost. Up to $1250 in compensation may be offered to study participants.

What the study will include over the course of 7 months

• Pre-screening phone interview
• Screening visits: to determine eligibility
• Blood draws, breathalyzer, questionnaires, and alcohol withdrawal assessments
• 9 in-person therapy sessions
• 2 dosing sessions with either psilocybin or placebo (50% chance of receiving active psilocybin)
• Keeping a daily e-diary of drinking days

Eligibility:

You may qualify as a study participant if:

• You are drinking on a daily or almost daily basis
• You agree to not consume psychoactive substances such as opioids, stimulants (amphetamines, cocaine, etc.), cannabinoids, or hallucinogens during your participation in the trial (approximately 7 months)
• You are otherwise generally healthy

Location:

The study requires you to participate in-person at the Surrey Neuroplasticity Clinic (located at Unit 1004, City Centre 3, 13761 96 Ave., Surrey, BC, V3V 0E8).

More study information:

Psilocybin-Assisted Psychotherapy in Adults with Alcohol Use Disorder

Contact:

Phone number: 778-584-0064
Email: [email protected]

Site Principal Investigator (Study Doctor):